我公司致力于為客戶提供高純度、低成本的活性重組蛋白，包括重組人淋巴細胞胞漿蛋白2(LCP2)在內(nèi)的各類受體、細胞因子、生長因子、轉(zhuǎn)錄因子、激素、酶、毒性蛋白、病毒抗原等。...

特別提示：包括重組人淋巴細胞胞漿蛋白2(LCP2)在內(nèi)，本公司的所有產(chǎn)品僅可用于科研實驗，嚴禁用于臨床醫(yī)療及其他非科研用途！

產(chǎn)品名稱：重組人淋巴細胞胞漿蛋白2(LCP2)
英文名稱：Recombinant Human Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa
產(chǎn)品貨號：JN1213
產(chǎn)品規(guī)格：10μg|50μg|500μg|1mg

本品由我們的大腸桿菌表達系統(tǒng)制備而成，目的基因編碼的Met1-Pro533在N端含T7標簽，C端含有His標簽。

LCP2質(zhì)量控制：＞95%(還原性SDS-PAGE)

LCP2制劑：液體

LCP2保存：收到貨后請置于-20℃，可保存6個月，避免反復(fù)凍融。

關(guān)于LCP2：
Lymphocyte cytosolic protein 2(LCP2)contains a SAM domain and a SH2 domain. It is highly expressed in spleen, thymus and peripheral blood leukocytes, T-cell and monocytic cell lines, but expressed at lower level in B-cell lines. LCP2 was originally identified as a substrate of the ZAP-70 protein tyrosine kinase following T cell receptor (TCR) ligation in the leukemic T cell line Jurkat. It is phosphorylated after T-cell receptor activation by ZAP70, ITK and TXK, which leads to the up-regulation of Th1 preferred cytokine IL-2 during post-translational modification. Studies using LCP2-deficient T cell lines or mice have provided strong evidence that SLP-76 plays a positive role in promoting T cell development and activation as well as mast cell and platelet function.

根據(jù)您的關(guān)注的重組人淋巴細胞胞漿蛋白2(LCP2)，重組Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa，重組LCP2，重組人LCP2，重組人淋巴細胞胞漿蛋白2，LCP2，重組淋巴細胞胞漿蛋白2，rhLCP2，重組人淋巴細胞胞漿蛋白2(LCP2)，重組人Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa，Recombinant Human Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa，rLCP2，JN1213，百奧萊博，，，您可能還對以下產(chǎn)品有需求：



名稱：重組人VEGF-A(VEGF165)
貨號：JN0224
規(guī)格：10μg|50μg|500μg|1mg
本品由我們的哺乳動物表達系統(tǒng)制備，目的基因編碼的Ala27-Arg191表達純化而來。

VEGF165質(zhì)量控制：＞95%(還原性SDS-PAGE)。

VEGF165制劑：凍干品

VEGF165保存：
凍干蛋白可在-20℃長期保存，室溫也可穩(wěn)定保存3周。
復(fù)溶蛋白溶液可在4～7℃保存2～7天。
復(fù)溶后建議分裝凍存在-20℃，可保存3個月，應(yīng)避免反復(fù)凍融。

VEGF165復(fù)溶：
1、試劑開蓋前請先離心。
2、復(fù)溶濃度應(yīng)大于100 μg/ml.
3、凍干蛋白溶于ddH2O中
4、復(fù)溶后根據(jù)使用量分裝保存，避免反復(fù)凍融。

關(guān)于VEGF165：
Human Vascular endothelial growth factor (VEGF), also known as VEGF-A and vascular permeability factor (VPF), belongs to the platelet-derived growth factor family of cysteine-knot growth factors. It is a potent activator in vasculogenesis and angiogenesis both physiologically and pathologically. VEGF-A has 8 differently spliced isoforms, of which VEGF165 is the most abundant one. VEGF165 is a disulfide-linked homodimer consisting of two glycosylated 165 amino acid polypeptide chains. VEGF stimulates the cellular response through binding to tyrosine kinase receptors VEGFR1 and VEGFR2 on the cell surface. It is widely accepted that VEGFR2 mediate almost all of the known cellular responses to VEGF while the function of VEGFR1 is less defined and is thought to modulate the VEGFR2 signaling.

關(guān)注重組人淋巴細胞胞漿蛋白2(LCP2)，重組Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa，重組LCP2，重組人LCP2，重組人淋巴細胞胞漿蛋白2，LCP2，重組淋巴細胞胞漿蛋白2，rhLCP2，重組人淋巴細胞胞漿蛋白2(LCP2)，重組人Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa，Recombinant Human Lymphocyte cytosolic protein 2/SH2 Domain-containing Leukocyte Protein of 76 kDa，rLCP2，JN1213，百奧萊博，，的同時，為您推薦更多您可能感興趣的產(chǎn)品：

貨號	名稱	規(guī)格
JN0207	重組人GM-CSF(哺乳動物表達)(含His標簽)	10μg|50μg|500μg|1mg
JN0232	重組人FGF21(成纖維生長因子21)	10μg|50μg|500μg|1mg
JN0286	重組人白介素8(IL-8)(Ser28-Ser99)	10μg|50μg|500μg|1mg
JN0289	重組人趨化因子CXCL4(PF4)	10μg|50μg|500μg|1mg
JN0360	重組人白介素20受體α(IR-20Rα)	10μg|50μg|500μg|1mg
JN1903	重組人半乳糖凝集素7	10μg|50μg|500μg|1mg

如果您覺得“JN1213 重組人淋巴細胞胞漿蛋白2”描述資料不夠齊全，請聯(lián)系我們獲取詳細資料。(聯(lián)系時請告訴我從給覽網(wǎng)看到的，我們將給您最大優(yōu)惠！)
本頁鏈接：http://m.mingjiewl.com/com_bjbiolab01/sell/itemid-8514251.html
已經(jīng)有888位訪客查看了本頁.